Biofrontera (BFRIW) Net Cash Flow (2020 - 2025)

Biofrontera's Net Cash Flow history runs 6 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• In Q4 2025, Net Cash Flow fell 3.17% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at -$8.1 million (down 276.42% YoY), while the FY2025 annual figure was $448000.0, down 90.18% from the prior year.
• Net Cash Flow was $2.9 million for Q4 2025 at Biofrontera, up from -$3.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $22.8 million in Q4 2021 to a low of -$10.4 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$1.0 million across 5 years, with a median of -$1.8 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Net Cash Flow soared 526.51% in 2021, then plunged 10894.68% in 2023.
• A 5-year view of Net Cash Flow shows it stood at $22.8 million in 2021, then tumbled by 145.37% to -$10.4 million in 2022, then jumped by 79.88% to -$2.1 million in 2023, then soared by 245.49% to $3.0 million in 2024, then slipped by 3.17% to $2.9 million in 2025.
• The last three Net Cash Flow figures came in at $2.9 million (Q4 2025), -$3.8 million (Q3 2025), and -$3.1 million (Q2 2025), per Business Quant data.